Long term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis - NAPSI
A Multi-center, Randomized, Vehicle-Controlled Study to Assess the Efficacy and Safety of Adalimumab in Combination with Topical Treatment (Calcipotriol/Betamethasone) in Subjects with Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE) - BELIEVE
A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral experienced, HIV-1 Infected Subjects
100 项与 Abbott GmbH (Germany) 相关的临床结果
0 项与 Abbott GmbH (Germany) 相关的专利(医药)
雅培贸易(上海)有限公司报告,由于涉及特定型号、特定批次产品,存在校准结果不理想,导致质量控制结果下降的问题。生产商Abbott GmbH 雅培德国有限责任公司对同型半胱氨酸测定试剂盒(化学发光微粒子免疫检测法Homocysteine Reagent Kit(注册证编号:国械注进20172400437)主动召回。召回级别为三级。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。 附件:医疗器械召回事件报告表 2022年8月10日附件4-2(企业召回报表) 雅培德国有限责任公司附件.pdf
100 项与 Abbott GmbH (Germany) 相关的药物交易
100 项与 Abbott GmbH (Germany) 相关的转化医学